LifeTech Scientific Corporation
LFTSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,304 | $1,267 | $1,097 | $925 |
| % Growth | 2.9% | 15.5% | 18.6% | – |
| Cost of Goods Sold | $322 | $272 | $223 | $178 |
| Gross Profit | $981 | $996 | $874 | $748 |
| % Margin | 75.3% | 78.6% | 79.6% | 80.8% |
| R&D Expenses | $303 | $298 | $208 | $146 |
| G&A Expenses | $165 | $149 | $102 | $97 |
| SG&A Expenses | $504 | $415 | $348 | $291 |
| Sales & Mktg Exp. | $340 | $265 | $245 | $194 |
| Other Operating Expenses | -$12 | -$100 | -$58 | -$16 |
| Operating Expenses | $795 | $612 | $498 | $421 |
| Operating Income | $186 | $383 | $376 | $329 |
| % Margin | 14.3% | 30.2% | 34.3% | 35.5% |
| Other Income/Exp. Net | $13 | -$208 | $2 | $4 |
| Pre-Tax Income | $199 | $176 | $378 | $333 |
| Tax Expense | $31 | $68 | $59 | $50 |
| Net Income | $222 | $263 | $325 | $292 |
| % Margin | 17.1% | 20.8% | 29.6% | 31.6% |
| EPS | 0.051 | 0.059 | 0.077 | 0.068 |
| % Growth | -13.6% | -23.4% | 13.2% | – |
| EPS Diluted | 0.051 | 0.059 | 0.074 | 0.064 |
| Weighted Avg Shares Out | 4,379 | 4,462 | 4,233 | 4,563 |
| Weighted Avg Shares Out Dil | 4,394 | 4,446 | 4,405 | 4,563 |
| Supplemental Information | – | – | – | – |
| Interest Income | $19 | $13 | $17 | $14 |
| Interest Expense | $2 | $1 | $1 | $3 |
| Depreciation & Amortization | $88 | $77 | $67 | $62 |
| EBITDA | $289 | $253 | $446 | $398 |
| % Margin | 22.2% | 20% | 40.6% | 43% |